Dashboard
Manage Tickers

NKTR NEKTAR THERAPEUTICS

Nasdaq nektar.com


$ 56.50 $ -0.97 (-1.66 %)    

Wednesday, 12-Nov-2025 19:19:09 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 619.53 $ -3.74 (-0.6 %)
DIA $ 482.77 $ 2.24 (0.47 %)
SPY $ 681.90 $ -1.55 (-0.23 %)
TLT $ 90.02 $ 0.16 (0.18 %)
GLD $ 387.00 $ 5.86 (1.54 %)
$ 57.67
$ 58.71
$ 56.40 x 405
$ 59.00 x 10
$ 56.25 - $ 59.18
$ 6.48 - $ 66.92
695,915
na
1.17B
$ 1.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-14-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-05-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-07-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-01-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-01-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-04-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nektar-therapeutics-enters-equity-distribution-agreement-with-piper-sandler--btig-may-sell-shares-worth-up-to-110m
Nektar Therapeutics Enters Equity Distribu...
11/12/2025 22:31:02

- SEC Filing

nektar-therapeutics-files-for-mixed-shelf-offering-size-not-disclosed
Nektar Therapeutics Files For Mixed Shelf ...
11/12/2025 21:46:30

- SEC Filing

reported-saturday-nektar-therapeutics-presents-late-breaking-rezolve-ad-data-showing-clinically-meaningful-easi-75-and-easi-90-improvements-at-acaai-2025
Reported Saturday, Nektar Therapeutics Pre...
11/10/2025 08:46:17

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo i...

nektar-therapeutics-q3-eps-187-beats-269-estimate-sales-11790m-beat-10048m-estimate
Nektar Therapeutics Q3 EPS $(1.87) Beats $...
11/06/2025 21:21:49

Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(1.87) per share which beat the analyst consensus estimate of $...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

nektar-therapeutics-announced-data-from-rezolve-ad-phase-2b-study-for-rezpegaldesleukin-accepted-for-late-breaking-oral-abstract-presentation-at-acaai-2025-annual-scientific-meeting
Nektar Therapeutics Announced Data From RE...
10/22/2025 12:06:17

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/03/2025 17:35:44

b-riley-securities-maintains-buy-on-nektar-therapeutics-raises-price-target-to-105
B. Riley Securities Maintains Buy on Nekta...
09/23/2025 18:09:04

B. Riley Securities analyst Mayank Mamtani maintains Nektar Therapeutics (NASDAQ:NKTR) with a Buy and raises the price targe...

btig-reiterates-buy-on-nektar-therapeutics-maintains-100-price-target
BTIG Reiterates Buy on Nektar Therapeutics...
09/19/2025 08:22:17

BTIG analyst Julian Harrison reiterates Nektar Therapeutics (NASDAQ:NKTR) with a Buy and maintains $100 price target.

nektar-therapeutics-announces-new-data-from-ongoing-rezolve-ad-phase-2b-study-of-rezpegaldesleukin-at-2025-eadv-congress
Nektar Therapeutics Announces New Data Fro...
09/18/2025 12:47:39

Study met primary and key secondary endpoints at week 16 in patients with moderate-to-severe atopic dermatitisHigh dose rezpega...

nektar-to-present-rezolve-ad-phase-2b-results-for-rezpegaldesleukin-in-atopic-dermatitis-at-eadv-2025-late-breaker-oral-session-on-sept-18-in-paris
Nektar To Present REZOLVE-AD Phase 2b Resu...
09/09/2025 11:04:23

whats-going-on-with-nektar-therapeutics-stock-on-thursday
What's Going On With Nektar Therapeutics S...
09/04/2025 18:52:30

Nektar Therapeutics stock is trading higher with no news, possibly due to Sanofi's disappointing results.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

shoe-carnival-american-eagle-ciena-victorias-secret-and-other-big-stocks-moving-higher-on-thursday
Shoe Carnival, American Eagle, Ciena, Vict...
09/04/2025 16:56:56

nektar-therapeutics-q2-eps-295-misses-292-estimate-sales-1118m-beat-1084m-estimate
Nektar Therapeutics Q2 EPS $(2.95) Misses ...
08/07/2025 20:16:56

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

fda-grants-nektar-therapeutics-fast-track-designation-for-rezpegaldesleukin-for-treatment-of-severe-to-very-severe-alopecia-areata
FDA Grants Nektar Therapeutics Fast Track ...
07/29/2025 13:06:32

b-riley-securities-maintains-buy-on-nektar-therapeutics-raises-price-target-to-85
B. Riley Securities Maintains Buy on Nekta...
07/08/2025 17:58:44

B. Riley Securities analyst Mayank Mamtani maintains Nektar Therapeutics (NASDAQ:NKTR) with a Buy and raises the price targe...

nektar-therapeutics-prices-underwritten-public-offering-of-100m-of-shares-at-2350shr
Nektar Therapeutics Prices Underwritten Pu...
07/01/2025 11:19:20

Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in...

us-stock-futures-slip-after-two-days-of-record-advances-fomo-could-add-another-5-10-says-expert
US Stock Futures Slip After Two Days Of Re...
07/01/2025 10:14:51

U.S. futures slipped on Tuesday after two days of record-setting advances. Futures of major benchmark indices were trading lower.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION